Harvest Fund Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-17,707
| Closed | -$1.18M | – | 807 |
|
|
2024
Q3 | $1.18M | Buy |
17,707
+5,544
| +46% | +$370K | 0.07% | 171 |
|
|
2024
Q2 | $1.44M | Sell |
12,163
-134
| -1% | -$15.9K | 0.1% | 116 |
|
|
2024
Q1 | $1.31M | Buy |
12,297
+8,910
| +263% | +$949K | 0.12% | 119 |
|
|
2023
Q4 | $333K | Buy |
3,387
+356
| +12% | +$35K | 0.05% | 160 |
|
|
2023
Q3 | $313K | Buy |
3,031
+1,123
| +59% | +$116K | 0.05% | 153 |
|
|
2023
Q2 | $232K | Buy |
1,908
+861
| +82% | +$105K | 0.05% | 176 |
|
|
2023
Q1 | $161K | Sell |
1,047
-1,052
| -50% | -$162K | 0.04% | 247 |
|
|
2022
Q4 | $373K | Buy |
2,099
+1,211
| +136% | +$215K | 0.1% | 127 |
|
|
2022
Q3 | $105K | Sell |
888
-644
| -42% | -$76.1K | 0.03% | 292 |
|
|
2022
Q2 | $219K | Sell |
1,532
-286
| -16% | -$40.9K | 0.06% | 158 |
|
|
2022
Q1 | $313K | Sell |
1,818
-870
| -32% | -$150K | 0.07% | 139 |
|
|
2021
Q4 | $673K | Sell |
2,688
-672
| -20% | -$168K | 0.11% | 75 |
|
|
2021
Q3 | $1.29M | Buy |
3,360
+596
| +22% | +$229K | 0.29% | 35 |
|
|
2021
Q2 | $649K | Buy |
2,764
+212
| +8% | +$49.8K | 0.07% | 67 |
|
|
2021
Q1 | $334K | Sell |
2,552
-324
| -11% | -$42.4K | 0.03% | 88 |
|
|
2020
Q4 | $300K | Buy |
2,876
+90
| +3% | +$9.39K | 0.03% | 108 |
|
|
2020
Q3 | $200K | Buy |
2,786
+901
| +48% | +$64.7K | 0.02% | 158 |
|
|
2020
Q2 | $116K | Sell |
1,885
-1,494
| -44% | -$91.9K | 0.01% | 213 |
|
|
2020
Q1 | $95K | Buy |
+3,379
| New | +$95K | 0.01% | 208 |
|